Skip to content

Bis-Triazole-Containing Heterocycles: Synthesis, Pharmacokinetic Prediction, Molecular Modeling, and Antimicrobial Activity Evaluation

Sep 2026 · Polycyclic aromatic compounds (Print) · Vol 46, pp. 1392 - 1420 · 0 citations · 59 references

TL;DR

The synthesis and evaluation of novel bis-triazole derivatives, designed to evaluate their antimicrobial activity against clinically relevant pathogens and to establish structure-activity relationships for future optimization, provide a basis for further optimization of triazole-based antimicrobial agents.

Abstract

Abstract The 1,2,4-triazole nucleus is a privileged scaffold in medicinal chemistry, as it is present in many clinically approved antifungal, anticancer and antiviral agents. However, the development of new triazole-based derivatives with better potency and safety profiles is demanded due to the emergence of antimicrobial resistance. The present study was designed to synthesize novel bis-triazole derivatives, to evaluate their antimicrobial activity against clinically relevant pathogens and to establish structure-activity relationships for future optimization. A new series of bis-triazole derivatives (2–14) was synthesized starting from isophthalic acid as the key intermediate 1. All compounds were characterized by FT-IR, NMR, mass spectrometry and analysis. The antimicrobial activity was determined by disk diffusion, MIC, MBC and MTT cytotoxicity assays. Molecular docking was done using redocking validation (RMSD = 0.92 Å) against DNA gyrase B (PDB: 1KZN). Compound 13 showed the best antibacterial activity (MIC = 12.5 µg/mL for K. pneumoniae; inhibition zone: 23 mm for E. coli). Compound 9 showed potent antifungal activity (19 mm vs C. albicans; MIC = 12.5 µg/mL vs MRSA). Selectivity indices ranged between 5 and 40 indicating good safety profiles. Docking showed that compound 13 had a binding energy of −8.8 kcal/mol with important interactions with ASP73, ARG136 and CYS393. First report of quantitative MIC, MBC and cytotoxicity data for this class of bis-triazole derivatives with evaluation against MDR clinical isolates (MRSA and K. pneumoniae). The validated docking model (RMSD = 0.92 Å) provides a reliable tool for future structure-based design. Compound 9 was found to be a promising oral antifungal lead (SI = 20) and compound 13 a candidate for topical antibacterial applications (SI = 10). These findings provide a basis for further optimization of triazole-based antimicrobial agents. GRAPHICAL ABSTRACTFlowchart illustrating the synthesis, profiling, docking, and toxicity evaluation of Bis-1,2,4-Triazole Diformimidate derivatives.The diagram presents a circular flowchart centered on "Bis-1,2,4-Triazole Diformimidate Derivatives," labeled '9'. Surrounding this structure are four main sections: "Synthesis & Characterization" with lab equipment and techniques (FT-IR, NMR, MS), "Molecular Docking" showing binding to the 1KZN protein, "Antimicrobial Activity" with illustrations of bacteria and fungi highlighting effectiveness, and "Toxicity Evaluation" featuring a spider web plot indicating low predicted toxicity for several categories. "ADME Profiling" indicates drug-likeness and bioavailability. Arrows represent the processes' interconnected workflow.

View source

Similar papers

Open access Sep 2026

Novel Peptide–Triazole Conjugates: Strategic Synthesis, Antimicrobial Properties, and Molecular Docking Study

A series of peptide–heterocycle conjugates was systematically designed and synthesized using solid‐phase peptide synthesis (SPPS), featuring octapeptide‐triazole conjugates modified with a triazole‐based moiety to create innovative antimicrobial agents characterized by enhanced stability and efficacy.

Jigar Bhavsar, S. Tivari, S. S. Pati et al. · 0 citations
Review Sep 2026

1,2,3-Triazole-Based Hybrids as Emerging Therapeutic Agents: Advances in Drug Design, Computational Studies, and Biological Applications.

INTRODUCTION The 1,2,3-triazole scaffold is a privileged heterocyclic motif in medicinal chemistry owing to its chemical stability, click-chemistry accessibility, and broad biological activity. This review examines advances in 1,2,3-triazole-based hybrids, emphasizing antitubercular activity against drug-sensitive and...

Mausin Khan, M. Ajmal, N. Shanthi et al. · 0 citations
Sep 2026

Molecular Diagnostic Studies and Synthesis of Bis-sulfonamide Triazine Derivatives as Antibacterial Agents: Insights from Molecular Docking: Insights from Molecular Docking

These triazine-based bis-sulfonamide derivatives represent a promising therapeutic scaffold for the development of next-generation bacterial DNA topoisomerase inhibitors and are evaluated for their in vitro antibacterial efficacy and non-cytotoxic profiles.

Tuhfa, M. Arshad, Mehnaj et al. · 0 citations
Open access Sep 2026

Design, synthesis, and biotechnological evaluation of Thiophene-based chalcones and Δ2-pyrazoline derivatives: Antibacterial, cytotoxic, and molecular docking studies

Antimicrobial resistance (AMR) and cancer are among the most extensively studied areas that still require further improvement. In the present study, four new compounds were synthesized via Claisen-Schmidt condensation reaction followed by ring closure, yielding pyrazoline heterocyclic derivatives bearing a thiophene mo...

I. S. Mahdi, Ghosoun Laftaa Mohsen, A. Abdula et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.